The Structural Effects of Hydration on Active Pharmaceutical Ingredients
Type of Proposal
Oral presentation
Faculty
Faculty of Science
Faculty Sponsor
Dr. Robert Schurko
Proposal
More than 50% of active pharmaceutical ingredients (APIs) are crystallized as simple salts, and of these, over 50% are HCl salts. In many instances, APIs can crystallize into pseudopolymorphic forms, such as hydrates or solvates, which have structures and molecular properties distinct from the non-hydrated or non-solvated solid phases. The polymorphic form of an API can influence its physicochemical properties, including bioavailability, shelf life, toxicity, and solubility. Additionally, each unique hydrate or solvate of an API represents unique intellectual property, and may be separately patented. As such, it is very important to precisely structurally characterize all solid forms of APIs. Numerous methods, such as single crystal X-ray diffraction (scXRD), powder X-ray diffraction (pXRD), and 13C NMR are often employed to accurately elucidate these structures. Previous work in our group has shown that 35Cl SSNMR can be extremely valuable in the study of APIs in both bulk and dosage forms. In particular, we have shown that 35Cl powder patterns are extremely sensitive to slight modifications in the molecular structure of an API, and serve as unique spectral fingerprints for each compound.1,2 The focus of this project is to use 35Cl SSNMR, pXRD, as well as quantum-chemical calculations, to systematically study hydrates and anhydrous forms of HCl APIs. By analyzing their 35Cl SSNMR spectra, we hope to study the hydrogen bonding interactions between chloride anions and water molecules, and the influence of water molecules on the molecular structures of the APIs. It is our hope that these proof of concept findings will be of interest to the pharmaceutical industry, for potential use in high throughput analysis of APIs, hydrate identification, and detection of impurities and disproportionation. 1. Hildebrand, M. et al. CrystEngComm 2014, 16, 7334. 2. Hamaed, H. et al. J. Am. Chem. Soc. 2008, 130, 11056.
Start Date
29-3-2016 4:00 PM
End Date
29-3-2016 5:00 PM
The Structural Effects of Hydration on Active Pharmaceutical Ingredients
More than 50% of active pharmaceutical ingredients (APIs) are crystallized as simple salts, and of these, over 50% are HCl salts. In many instances, APIs can crystallize into pseudopolymorphic forms, such as hydrates or solvates, which have structures and molecular properties distinct from the non-hydrated or non-solvated solid phases. The polymorphic form of an API can influence its physicochemical properties, including bioavailability, shelf life, toxicity, and solubility. Additionally, each unique hydrate or solvate of an API represents unique intellectual property, and may be separately patented. As such, it is very important to precisely structurally characterize all solid forms of APIs. Numerous methods, such as single crystal X-ray diffraction (scXRD), powder X-ray diffraction (pXRD), and 13C NMR are often employed to accurately elucidate these structures. Previous work in our group has shown that 35Cl SSNMR can be extremely valuable in the study of APIs in both bulk and dosage forms. In particular, we have shown that 35Cl powder patterns are extremely sensitive to slight modifications in the molecular structure of an API, and serve as unique spectral fingerprints for each compound.1,2 The focus of this project is to use 35Cl SSNMR, pXRD, as well as quantum-chemical calculations, to systematically study hydrates and anhydrous forms of HCl APIs. By analyzing their 35Cl SSNMR spectra, we hope to study the hydrogen bonding interactions between chloride anions and water molecules, and the influence of water molecules on the molecular structures of the APIs. It is our hope that these proof of concept findings will be of interest to the pharmaceutical industry, for potential use in high throughput analysis of APIs, hydrate identification, and detection of impurities and disproportionation. 1. Hildebrand, M. et al. CrystEngComm 2014, 16, 7334. 2. Hamaed, H. et al. J. Am. Chem. Soc. 2008, 130, 11056.